Cohance Lifesciences Limited (NSE:COHANCE)

Cohance Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	596.6	1,025	472.3	648.03	445.64
Short-Term Investments	-	2,663	1,917	-	-	-
Trading Asset Securities	-	-	-	7,739	4,189	4,812
Cash & Short-Term Investments	3,260	3,260	2,942	8,211	4,837	5,258
Cash Growth	16.25%	10.79%	-64.17%	69.75%	-8.00%	180.01%
Accounts Receivable	-	6,810	7,721	1,337	1,109	2,364
Other Receivables	-	19	121.1	562.3	665.92	480.04
Receivables	-	6,909	7,867	1,907	1,777	2,846
Inventory	-	5,622	4,674	2,332	3,306	3,000
Prepaid Expenses	-	-	-	49.2	86.28	64
Other Current Assets	-	2,489	2,452	32.7	103.79	111.67
Total Current Assets	-	18,280	17,935	12,532	10,110	11,279
Property, Plant & Equipment	-	21,633	20,964	7,868	7,662	5,620
Long-Term Investments	-	2,622	1,454	1,306	1,171	1,171
Goodwill	-	12,837	12,390	602.5	602.58	-
Other Intangible Assets	-	995.2	1,064	16.8	19.32	22.36
Long-Term Deferred Tax Assets	-	26.4	5.5	8.1	-	-
Other Long-Term Assets	-	890.6	889.6	216	91.64	203.02
Total Assets	-	57,296	54,810	22,549	19,657	18,296

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	2,846	2,684	423.5	700.92	1,059
Accrued Expenses	-	472.9	455.6	256.9	128.17	266
Short-Term Debt	-	-	-	385.8	445.98	471.33
Current Portion of Long-Term Debt	-	1,192	1,286	-	200	200
Current Portion of Leases	-	252.5	364.5	51.9	4.79	10.91
Current Income Taxes Payable	-	164.4	75.2	-	2.94	36.42
Current Unearned Revenue	-	-	-	6.9	8.08	-
Other Current Liabilities	-	1,532	2,188	49	96.79	59.27
Total Current Liabilities	-	6,459	7,054	1,174	1,588	2,103
Long-Term Debt	-	504.8	1,298	-	45.64	284.4
Long-Term Leases	-	2,056	1,911	212.4	7	4.63
Pension & Post-Retirement Benefits	-	4	2.6	-	-	11.09
Long-Term Deferred Tax Liabilities	-	979	1,026	656	582.35	543.15
Other Long-Term Liabilities	-	6,955	5,590	-	82.95	77.85
Total Liabilities	-	16,958	16,881	2,042	2,306	3,024

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	382.6	254.6	254.6	254.57	254.57
Additional Paid-In Capital	-	-	-	1,096	1,096	1,096
Retained Earnings	-	-	-	18,894	15,894	13,820
Comprehensive Income & Other	-	38,730	36,234	262.3	107.17	101.65
Total Common Equity	39,113	39,113	36,488	20,507	17,352	15,272
Minority Interest	-	1,225	1,441	-	-	-
Shareholders' Equity	40,338	40,338	37,929	20,507	17,352	15,272
Total Liabilities & Equity	-	57,296	54,810	22,549	19,657	18,296

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	4,005	4,005	4,859	650.1	703.41	971.27
Net Cash (Debt)	-745.1	-745.1	-1,917	7,561	4,134	4,287
Net Cash Growth	-	-	-	82.90%	-3.56%	858.10%
Net Cash Per Share	-	-1.95	-4.99	29.70	16.24	16.84
Filing Date Shares Outstanding	-	383.33	382.57	254.56	254.56	254.56
Total Common Shares Outstanding	-	383.33	254.56	254.56	254.56	254.56
Working Capital	-	11,820	10,881	11,358	8,523	9,176
Book Value Per Share	102.03	102.03	143.34	80.56	68.16	59.99
Tangible Book Value	25,281	25,281	23,035	19,887	16,730	15,249
Tangible Book Value Per Share	65.95	65.95	90.49	78.12	65.72	59.90
Land	-	-	-	150.5	150.46	150.46
Buildings	-	-	-	2,206	2,200	1,813
Machinery	-	-	-	5,797	5,410	4,750
Construction In Progress	-	-	-	1,790	1,651	299.94
Leasehold Improvements	-	-	-	42.6	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error